T2C2 Capital
North America, Quebec, Canada, Montréal
Description
T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry,
Investor Profile
T2C2 Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C rounds (top funding stages).
- Majority of deals are located in Canada, Israel, France.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series B (75%)
- Series C (25%)
Country Focus
- Canada (50%)
- Israel (25%)
- France (25%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Biopharma
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
